コンテンツへスキップ
Merck
  • Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrate.

Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrate.

Organic letters (2014-06-24)
Atsushi Nakayama, Akinori Okano, Yiqing Feng, James C Collins, Karen C Collins, Christopher T Walsh, Dale L Boger
要旨

Studies on the further development of the sequential glycosylations of the vancomycin aglycon catalyzed by the glycosyltransferases GtfE and GtfD and the observation of unusual, perhaps unexpected, aglycon substrate substituent effects on the rate and efficiency of the initial glycosylation reaction are reported.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
バンコマイシン 塩酸塩 Streptomyces orientalis由来, ≥900 μg per mg (as vancomycin base)
Sigma-Aldrich
バンコマイシン 塩酸塩 Streptomyces orientalis由来, ≥85% (Vancomycin B)
Sigma-Aldrich
バンコマイシン 塩酸塩 Streptomyces orientalis由来, BioReagent, suitable for plant cell culture
Sigma-Aldrich
バンコマイシン 塩酸塩 Streptomyces orientalis由来, meets USP testing specifications
Sigma-Aldrich
ホスホリラーゼb ウサギ筋肉由来, lyophilized powder, ≥20 units/mg protein, 2× crystallization
Millipore
バンコマイシン 塩酸塩, suitable for microbiology
バンコマイシン 塩酸塩, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
ホスホリラーゼb ウサギ筋肉由来, For use as a marker in SDS-PAGE